On matters of the heart, women aged 40-plus naive when it comes to risks

    ~ Still considered a "man's disease," women face major disconnect between
    concern about heart disease, high cholesterol and efforts to monitor and
    control it ~

    OTTAWA, June 3 /CNW/ - Heart disease is the number one killer of women in
this country,(1) but a new survey from the Federation of Medical Women of
Canada (FMWC) reveals that many Canadian women still possess little knowledge
about their own risk factors for cardiovascular disease, including their
personal cholesterol target levels, and appear not to be taking the time to
address these risk factors.
    Results from the LIPitor: Women'S InsighTs Into Cholesterol Knowledge
(LIPSTICK) survey, conducted by Leger Marketing, reveal that while nearly all
Canadian women aged 40-plus (94 per cent) say that having healthy cholesterol
levels are important to them, the reality is that cholesterol is not
top-of-mind. According to LIPSTICK, nearly half of women surveyed (46 per
cent) spend the most time thinking about their weight, versus only five per
cent who think about their cholesterol levels. In fact, only one-in-ten women
surveyed knew their personal LDL ("bad" cholesterol) levels, versus the more
than six-in-ten women (64 per cent) who know how much they weighed in high
    LIPSTICK further revealed that four-in-ten women aged 40-plus have not
had their cholesterol checked in the past year, despite the risk of elevated
cholesterol and heart disease increasing with age. Moreover, although
three-in-ten Canadian women surveyed have been diagnosed with high
cholesterol, one-in-six of those do not get their cholesterol levels checked
on a yearly basis.
    "Knowing all your vascular risk factors such as high blood pressure,
diabetes, lack of exercise, high cholesterol, obesity and smoking, is a very
important step in the prevention of heart disease," says Dr. Nahid Azad,
Associate Professor, University of Ottawa and a member of the Federation of
Medical Women of Canada (FMWC). "The good news is it is never too late to take
action. Women need to work with their physician to identify their personal
risk, and steps they can take to reduce their chances of cardiovascular
disease, through diet and lifestyle changes, and medication if necessary."


    Shockingly enough, more than half of Canadian women surveyed are unaware
of the fact that more women than men die of heart disease every year. Heart
disease and stroke kill one-third of women, and women are more likely than men
to die of a heart attack or stroke.(2)
    Although the odds are against them, LIPSTICK reveals few women
acknowledge their personal risk for heart disease. More than one-third of
Canadian women surveyed (37 per cent) may underestimate their own risk for
heart disease, believing they are "not at risk" for developing heart disease,
or only to a "very small extent," while most women fail to make the connection
between risk factors, such as high cholesterol, and their personal chance of
developing heart disease. The reality is that an alarming 80 per cent of
Canadian women surveyed report having two or more risk factors - such as age,
diabetes, high cholesterol and/or high blood pressure - which puts them at an
increased risk for heart attack and stroke.
    "Heart disease is not just a man's disease - the truth is more women than
men face the threat of a heart attack or stroke," says Dr. Azad.
"Traditionally women have put the needs of their family ahead of their own;
however, when it comes to their health, women need to start making themselves
a priority. LIPSTICK reinforces the need for Canadian women to start taking
heart disease personally."


    Perhaps what is of most concern is women who have been diagnosed with
high cholesterol are not doing enough to reduce their risk of cardiovascular
disease. LIPSTICK reveals that 15 per cent of Canadian women diagnosed with
high cholesterol are not exercising in an effort to improve their overall
health and reduce their cholesterol levels and subsequent risk for
cardiovascular disease. For the majority, the reason for not exercising is
simply a lack of motivation.
    "My father passed away from a massive heart attack and this was a huge
wake up call for me to go to my doctor to find out my own risk for heart
disease," says Rita Cascagnette, aged 43. "After my doctor diagnosed me with
high cholesterol, I started to pay more attention to my own health. I now
exercise regularly, watch what I eat and help manage my high cholesterol with
a statin."

    About LIPSTICK

    LIPSTICK was conducted to determine the level of cardiovascular knowledge
held by Canadian women, as well as awareness of risk factors, including high
cholesterol. LIPSTICK explored women's perceptions and understanding of heart
disease to improve management of high cholesterol.
    A total of 2,000 Canadian women aged 40-plus answered an on-line survey.
Results of a sample this size comprised of Canadians can be considered
accurate to +/- 2.2 per cent, 19 times out of 20. LIPSTICK was undertaken in
consultation with the Federation of Medical Women of Canada and conducted by
Leger Marketing. LIPSTICK was supported by an unrestricted educational grant
from Pfizer Canada Inc.


    The Federation of Medical Women of Canada (FMWC) is a national
organization committed to the professional, social and personal advancement of
women physicians and to the promotion of the well-being of women both in the
medical profession and in society at large. Since its formation in 1924, the
FMWC has acted as a guardian for women physicians and medical students, giving
loans, mentoring and networking opportunities, and acting as an advocate for
women physicians and women's health in society.
    Most of the women physician leaders in Canada have received their
training and support through membership in FMWC, which is an independent
national member of the Medical Women's International Association.


    Pfizer Canada Inc. is the Canadian operation of Pfizer Inc., the world's
leading pharmaceutical company. Pfizer discovers, develops, manufactures and
markets prescription medicines for humans and animals. Pfizer's ongoing
research and development activities focus on a wide range of therapeutic areas
following our guiding aspiration: working for a healthier world. For more
information, visit www.pfizer.ca.

    Video B-roll Available via Satellite: Tuesday, June 3, 2008
    10:00 to 10:30 and again at 14:35 to 15:05 EST

    Anik F2, C-Band, Transponder 7B @111.1 West
    Vertical Polarization, D/L Freq. 3980MHz.
    Audio subcarriers 6.8 left, 6.2 right

    Also Available at Toronto T.O.C. Magnacom NOVSXS 225340 - 002
    (SDI Router Position No. 42)

    (2) Investing in Canada's Future 2003-2004, Canadian Institutes of Health
Research (CIHR), 2004.

For further information:

Binns, Dana Allison, Carolyn Santillan, Edelman, Tel: (416) 979-1120, ext.
257, 318, 351, whitney.binns@edelman.com, dana.allison@edelman.com,
carolyn.santillan@edelman.com; Alexandra Menear, Edelman, (Montreal), Tel:
(514) 844-6665, ext. 226, alexandra.menear@edelman.com; Christian Marcoux,
Manager, Corporate Communications, Pfizer Canada Inc., Tel: (514) 426-6985,

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890